The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor cell (CTC) expression patterns of cell surface targets in metastatic prostate cancer.
 
Kendra Marr
No Relationships to Disclose
 
Jamie Sperger
No Relationships to Disclose
 
Amy Taylor
No Relationships to Disclose
 
Katharine Tippins
No Relationships to Disclose
 
Shannon Reese
No Relationships to Disclose
 
Kyle Helzer
Employment - Epic Systems (I)
 
Matthew Bootsma
Employment - Luminex (I)
 
Grace Blitzer
Employment - UW Health
 
John Floberg
No Relationships to Disclose
 
David Kosoff
No Relationships to Disclose
 
Rana McKay
Consulting or Advisory Role - Ambrx; Ambrx; Arcus Biosciences; Astellas Medivation; AstraZeneca; AVEO; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Esiai; Exelixis; Janssen; Lilly; Merck; Myovant Sciences; NeoMorph; Novartis; Pfizer; Sanofi; Seagen; Sorrento Therapeutics; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tempus; Vividion Therapeutics
Research Funding - Artera (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Exelixis (Inst); Oncternal Therapeutics (Inst); Tempus (Inst)
 
Xiao Wei
Honoraria - OncLive
Consulting or Advisory Role - Dendreon; Novartis; Novartis; Novartis; Novartis
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Corvus Pharmaceuticals; Novartis
 
Shuang Zhao
Employment - Artera (I)
Stock and Other Ownership Interests - Exact Sciences (I)
Patents, Royalties, Other Intellectual Property - Patent applications pending (Inst); Patent applications pending licensed to Veracyte (Inst)
 
Joshua Lang
Consulting or Advisory Role - 4D Pharma; 4D Pharma; Arvinas; AstraZeneca; Foundation Medicine; Gilead Sciences; Immunomedics; Janssen; Macrogenics; Pfizer; Pfizer/Astellas; Pfizer/Myovant; Sanofi
Research Funding - Agensys (Inst); Arvinas (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Janssen (Inst); Medivation (Inst)
Patents, Royalties, Other Intellectual Property - I am listed on the patent on a technology for rare cell capture and analysis. This technology has been licensed by Salus Discovery, LLC though no commercial products are available.
 
Marina Sharifi
No Relationships to Disclose